Engaged Capital's Q4 moves include BlackLine, Nevro exits, new stake in Chart Industries
Engaged Capital exited its stakes in BlackLine ( NASDAQ: BL) and Nevro ( NYSE: NVRO) and took a new position in Chart ...
GlobalData on MSN4d
Globus Medical strengthens SCS market position with $250m Nevro deal
GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
Dexcom, Inc.'s (NASDAQ:DXCM) fourth-quarter revenue rose 8% year-over-year to $1.114 billion, beating the analyst consensus ...
FierceBiotech4d
Globus Medical to buy neurostim developer Nevro for $250M
Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
Hosted on MSN6d
Piper Sandler Upgrades Nevro (NVRO)
Fintel reports that on February 7, 2025, Piper Sandler upgraded their outlook for Nevro (NYSE:NVRO) from Underweight to ...
Nevro (NYSE:NVRO) Stock Rating Upgraded by Jefferies Financial Group
Nevro (NYSE:NVRO – Get Free Report) was upgraded by research analysts at Jefferies Financial Group from an “underperform” rating to a “hold” rating in a research note issued to investors on Monday, ...
Analysts Offer Insights on Healthcare Companies: Nevro Corp (NVRO) and Ansell (OtherANSLF)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Corp (NVRO – Research Report) and Ansell (ANSLF – ...
Nevro Corp (NVRO) Receives a Hold from Wells Fargo
In a report released on February 7, Nathan Treybeck from Wells Fargo maintained a Hold rating on Nevro Corp (NVRO – Research Report), with a ...
The Globe and Mail6d
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
AUDUBON, Pa. and REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical device ...